Both in Biotechnology
Century Therapeutics vs X4 Pharmaceuticals
Over the past year IPSC returned +187.5% and XFOR returned −3.8%; their daily moves had a correlation of 0.18.
IPSC +187.5% XFOR −3.8%Growth of $1, one year, split-adjusted
| Metric | IPSC | XFOR |
|---|---|---|
| Price | $1.64 | $3.02 |
| Market cap | $297.0M | $299.4M |
| Today | +11.56% | +9.82% |
| 1 month | −11.4% | −13.6% |
| 6 months | −28.7% | −27.6% |
| Year to date | +64.9% | −24.5% |
| 1 year | +202.4% | +1.7% |
| Revenue growth (YoY) | — | +346.3% |
| Gross margin | — | 81.6% |
| Net margin | — | −183.5% |
| P/E (TTM) | — | — |
| Price / sales | — | 18.9× |
| Net cash | $119.7M | $131.2M |
| Dividend yield | — | — |
| Volatility (60d) | 75.1% | 66.0% |
| Short % of float | 23.4% | 9.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).